Navigation Links
Maryland Stem Cell Research Commission Funds 36 New Projects in FY 2011

COLUMBIA, Md., May 25, 2011 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) has completed its review of the 180 applications received in response to its three FY 2011 Requests for Applications (RFAs). The board of directors of the Maryland Technology Development Corporation (TEDCO) approved the Commission's recommendation to fund 36 new projects with the Maryland Stem Cell Research Fund's (MSCRF) $10.4 million FY 2011 budget.

As highlighted in its 2011 RFAs, the Commission gave preference to proposals that focus on advancing regenerative medicine, by selecting promising research that addresses osteoporosis, traumatic brain injuries, heart disease, cancer, diabetes, schizophrenia, ALS, autism, DNA damage, intestinal tissue generation, clinical drug screenings, and other debilitating and costly medical conditions. This funding cycle, the Commission also encouraged collaborations, resulting in 10 awardees (more than 25 percent) proposing to work with private biotech companies. In a groundbreaking new pilot program, two MSCRF-funded researchers will collaborate with scientists funded by the California Institute of Regenerative Medicine (CIRM). These two projects, studying red blood cell production and traumatic axonal injuries, will leverage Maryland's investment in stem cell research with more than $7 million in CIRM funding.

"Each year, Maryland's stem cell research program is a national leader in research and innovation while creating jobs and stimulating our State economy," said Governor Martin O'Malley. "I'd like to congratulate this year's awardees, and we look forward to their contributions to the field."

This year's MSCRF awards include:

  • 9 Investigator-Initiated Research Grants (RFA-MD-11-01) - providing up to $200,000 of direct costs per year, for up to three years, to investigators with preliminary data to support their hypotheses;

  • 13 Exploratory Research Grants (RFA-MD-11-02) - providing up to $100,000 of direct costs per year, for up to two years, to new stem cell researchers (young investigators and scientists from other fields), for new approaches, mechanisms or models that may differ from current thinking in the field and/or new hypotheses that have little or no preliminary data; and

  • 14 Post-Doctoral Fellowship Research Grants (RFA-MD-11-03) - providing up to $55,000 per year, for up to two years, including direct and indirect costs and fringe benefits, to post-doctoral fellows.  

All MSCRF-funded research must be conducted in Maryland, and must involve human stem cells.

For a complete list of the names of the Principal Investigators (PIs), their project titles and institutions, please visit the awardees section of the website (

Each grant awarded by the Commission is contingent upon the PI obtaining all applicable ethical approvals to conduct the specified research, as well as a signed agreement with TEDCO that describes the scope of the project, requirements for sharing any cell line(s) developed with MSCRF funding and a commitment to publish results.

"We are pleased to announce the MSCRF grant awards for FY 2011," said Margaret Conn Himelfarb, MPH, chair of the Commission. "These projects exemplify Maryland's investment in world-class, cutting-edge research. We are delighted that our collaboration with the California Institute of Regenerative Medicine will significantly augment State funding, establish new teams of expert investigators and expedite advances in regenerative medicine. The Commission is grateful to Governor O'Malley and our legislators for their visionary leadership and ongoing support of stem cell research. This pioneering science will continue to return dividends to our State."

The final amount of each award will be determined during the due diligence process and will be listed in the MSCRF annual report scheduled for release in December 2012. All currently funded MSCRF researchers are required to present their findings at the 4th Annual Maryland Stem Cell Research Symposium to be held on October 6, 2011 at Towson University.  

About the Maryland Stem Cell Research Commission

The Maryland Stem Cell Research Fund (MSCRF) was established by the State of Maryland under the Maryland Stem Cell Research Act of 2006 to promote State-funded stem cell research and cures through grants and loans to public and private entities in the State. Administered by The Maryland Technology Development Corporation (TEDCO), the MSCRF is overseen by an independent Commission that sets policy and develops criteria, standards and requirements for applications to the Fund. The current MSCRF budget for FY2012 is $12.4 million. For more information about the Maryland Stem Cell Research Fund and a list of Commission members, please visit

Media Contact:

Kathleen Shaffer

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE Maryland Stem Cell Research Commission
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Novavax Named Biotechnology Firm of the Year by Tech Council of Maryland
2. Mtech Announces Winners of the 2011 University of Maryland $75K Business Plan Competition
3. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
4. The University of Maryland Baltimore (UMB) and Paragon Bioservices, Inc. Announce the Formation of a Public-Private Stem Cell Technology Consortium
5. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
6. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
7. Maryland Governor Martin OMalley to Visit Novavax in Celebration of HHS-BARDA Contract Award
8. Biophysical Society to Hold 55th Annual Meeting in Baltimore, Maryland, March 5-9, 2011
9. CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington
10. Maryland Stem Cell Research Commission to Host Third Annual Maryland Stem Cell Research Symposium
11. Governor OMalley Announces State Grants Available For Maryland Bio Companies
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
Breaking Biology Technology:
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a global ... it has released a new version of its ... North America have already installed ... also includes a FIDO UAF certified server component ... preparing to activate FIDO features. These customers include some ...
(Date:10/29/2015)... , Oct. 29, 2015 Today, ... a partnership with 2XU, a global leader in ... a smart hat with advanced bio-sensing technology. The ... athletes to monitor key biometrics to improve overall ... partnership, the two companies will bring together the most ...
(Date:10/26/2015)... PUNE, India , October 26, ... --> --> ... Forecasts 2015 to 2021 as well ... Analysis 2015-2019 research reports to its ... . ...
Breaking Biology News(10 mins):